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1. Introduction 
The enzyme forming poly ADPR seems to be re- 
lated to DNA in a yet unknown manner. The exclusive 
localisation in the nucleus [l-3] , the even distribu- 
tion over the chromatin [4, 51, the firm association 
with nuclear proteins (6, 71, its inhibitory action on 
“endogenous” DNA polymerase activity [ 81, and the 
correlation of poly ADPR polymerase activity with 
the DNA content of various malignant and non- 
malignant tissues [9] point to a close connection 
with the nuclear DNA. In spite of these findings, 
however, the true function of the polymer is still 
obscure, and additional information is needed. We 
wish to report on a highly specific inhibition of the 
poly ADPR-forming enzyme from HeLa cells by 
thymidine and by nicotinamide. 
2. Materials 
Enzymes, coenzymes, analogues of NAD and nico- 
tinamide were obtained from E. Merck (Darmstadt, 
Germany), from Boehringer u. Soehne (Mannheim, 
Germany), and from Nutritional Biochemicals (Cleve- 
land, Ohio). 5Methyl nicotinamide was a generous 
gift of Dr. J.B. Clark, London. HeLa S3 cells were 
Abbreviations. 
UR = uridine 
UDR = 2’-deoxy uridine 
FUDR = S-fluori-deoxy uridine 
BUR = 5-bromo uridine 
BUDR = S-bromo-2’-deoxy uridine 
JUDR = S-iodo-2’-deoxy uridine 
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propagated in modified Joklik medium (Grand 
Island Biological Co., Grand Island, USA) with 5% 
calf serum in suspension culture [lo]. 
3. Results and discussion 
During experiments with synchronized HeLa 
cell cultures it was observed that thymidine had a 
pronounced effect on poly ADPR polymerase. As 
shown in table 1, a dose-dependent inhibition 
occurs at concentrations used to block DNA synthe- 
sis and cell proliferation. This effect of thymidine is 
highly specific (table 2). From all “natural” bases 
and nucleosides tested only thymine produced a com- 
parable inhibition. The thymidine analogues BUR, 
BUDR, and JUDR were also effective, while the 
uridine analogue FUDR showed only small effects. 
The increasing efficiency in the series UR-UDR- 
FUDR-BUR-BUDR again points to the highly 
specific structural requirements for inhibition of 
the enzyme by thymidine. It seems important to 
point out that thymidine nucleotides showed but 
a weak retardation of enzyme activity. Similar ob- 
servations could be made with partially purified 
enzyme from Ehrlich carcinoma and from murine 
mastocytoma (not shown). 
There is another type of inhibitor with a similarly 
high specificity: nicotinamide. Effective concentra- 
tions were in the same range as thymidine. The re- 
tarding action of nicotinamide on the poly ADPR 
forming enzyme has been noted by others [ 13, 141. 
Its type of inhibition is competitive, as we have 
shown previously [ 14, cf. also 151. This is somewhat 
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Table 1 Table 2 
Dose-dependent inhibition of poly ADPribose polymerase 
by thymidine. 
Specific inhibition of,po!y.AlYPR polymerase in HeLa 3 
nuclei-by thpmidine and thymine. 
Addition Poly ADPR polymerase 
activity 
(cpm incor- 
porated 
(%) 
none 450 * 65 100 
Thymidine 3 X 10d4 M 290 64 
Thymidine 1 X 10e3 M 175 39 
Thymidine 3 X 10e3 M 80 17 
Thymidine 1 X lo-’ M 20 4 
Thymidine added 
after incubation 
1 x lo-’ M 430 95 
Samples containing 100 mM Tris-HCl buffer pH 8.4; 
2.4 mM MgC12; 1 mM Clelands reagent; 1 mM 3H-p-NAD 
(2 X lo4 cpm), and nuclei corresponding to 15 I.cg DNA 
in 150 total volume were incubated at 25” for 45 min. 
100 ~1 were then spotted onto filter papers, dried, and 
analyzed for acid insoluble radioactivity according to [ 111. 
Nuclei were prepared from HeLa S3 cells propagated in 
suspension culture [lo] . Cells (1.5 X 1 08) were washed 
and treated with 5 ml 10 mM Tris buffer pH 7.4- 10 mM 
KC1 - 1.5 mM MgClz at 0” for 15 min, and then broken 
up in a Dounce homogenizer (B. Braun, Melsungen) until 
less than 1% of unbroken cells were left. Nuclei were washed 
3X in isotonic sucrose containing Tris-KCl-MgClz buffer, 
and finally suspended in 3 ml of this solution. DNA was 
determined according to [ 121. 
Additions Poly ADPR polymerase activity 
(1 x 1O-3 M) (cpm incorporated) (% of control) 
None 3,470 + 80 100 
Adenine 2,750 * 140 19 
Guanine 2,820 f 60 81 
Uracil 3,000 f 170 86 
Cytosine 3,370 + 210 96 
Hypoxanthine 2,790 f 200 80 
Thymine 8705 9 25 
Adenosine 3,160 ? 150 91 
Guanosine 3,180 + 150 91 
Uridine 3,340 f 70 96 
Cy tidine 3,185 f 50 91 
Inosine 3,250 f 190 93 
Deoxy adenosine 3,400 f 20 97 
Deoxy guanosine 2,810 * 30 81 
Deoxy uridine 3,050 + 60 87 
Deoxy cytidine 3,490 i 50 100 
Deoxy thymidine 490 -r 30 14 
BUR 610* 25 18 
BUDR llO+ 10 3 
FUDR 2,980 ? 110 86 
Deoxy TMP 2,770 f 80 80 
Deoxy TTP 3,120? 60 90 
Nuclei corresponding to 60 pg DNA were incubated under 
the conditions described in the legend to table 1. 
shown). Still, it appears that nicotinamide, too, is 
a unique inhibitor of poly ADPR polymerase of 
HeLa S3 (and of Ehrlich carcinoma) cells. 
surprising since the inhibition by nicotinamide 
proved also very specific with the HeLa enzyme 
(table 3). Even 3-acetyl pyridine was not able to 
substitute for nicotinamide but to a very limited 
degree. Only S-methyl nicotinamide could replace 
nicotinamide as an inhibitor to some extent. Also, 
NMN had no affinity at the applied concentration 
which corresponded to the concentration of the 
substrate NAD in the test. The high specificity of 
the enzyme extends to the dinucleotide level. 
Neither NADP nor 3-acetyl pyridine NAD, which 
can substitute NAD in all dehydrogenase systems, 
was able to inhibit significantly the enzyme at equi- 
molar concentrations. There are rare exceptions 
like CC-NAD or thio-NAD which inhibit the enzyme 
competitively to a somewhat higher degrbe (not 
The physiological significance of the specific 
inhibition of poly ADPR polymerase by the two 
metabolites is not clear. While the concentrations 
needed for inhibition of the nuclear enzyme are 
well above the levels found in tissues (equal distri- 
bution assumed), the high specificity of the effects 
may indicate yet unknown correlations. In the case 
of a thymidine block applied to HeLa cultures 
(2 mM thymidine) the enzyme should be nearly 
completely inhibited. Whether this is related to the 
inhibition of DNA synthesis, observed under these 
conditions, or to the variations of poly ADPR poly- 
merase during the cell cycle [ 16- 181 remains to 
be determined. 
Nicotinamide at 1 mM and 3 mM concentrations 
elevated NAD content in HeLa cells, but acted 
differently on cell proliferation [ 191. At 1 mM 
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Table 3 
Specificity of nicotinamide inhibition. 
Additions 
Poly ADPR 
polymerase 
(relative 
activity) 
None 100 
Nicotinamide 1 X 1O-3 M 49 
3 X 1O-3 M 26 
Nicotinate 3 X 1O-3 M 94 
Pyridine-3-hydroxamate 1 X 1O-3 M 102 
3 X 1O-3 M 110 
Pyridine-3-sulfonate 1 X 1O-3 M 99 
3 X 1O-3 M 109 
3-Acetyl-pyridine 1 X 1O-3 M 86 
3 X 1O-3 M 99 
Nicotinonitrile 1 X 1O-3 M 98 
3 X 1O-3 M 108 
Nicotinate-N-ethylamide 1 X 10m3 M 95 
Isonicotinyl hydrazide 1 X 1O-3 M 101 
6-Amino-nicotinamide 1 X 1O-3 M 84 
6Chloro-nicotinamide 1 X 1O-3 M 104 
5-Methyl nicotinamide 1 X 1O-3 M 70 
NMN 
NADP 
3-Acetylpyridine-NAD 
Deamino-NAD 
1 X 1O-3 M 87 
1X 10-3M 89 
1 X 1O-3 M 86 
1 X 1O-3 M 100 
Mean values from 2-4 determinations with HeLa nuclei. 
The controls correspond to 27.3 f 1.1 cpm/pg DNA in- 
corporated into the acid-insoluble polymer under the 
conditions described in table 1. 
nicotinamide, there was a slight stimulation (to 
107- 125%), while 3 mM nicotinamide inhibited 
cell proliferation (by lo-30%). In both cases, 
however, poly ADPR polymerase activity should 
be partially inhibited, provided intracellular nico- 
tinamide levels approach outside concentrations. 
These observations have some bearing on a postulate 
of Burzio and Koide [8] that the proliferation- 
inhibiting action of nicotinamide [20] should come 
about by an elevation of NAD concentration which 
in turn would increase poly ADPR formation and 
thus inhibit DNA synthesis. This postulate did not 
take into account the inhibitory action of nico- 
tinamide on the poly ADPR-forming enzyme. 
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